루푸스 치료제 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년까지 연평균 8.7%의 성장률(CAGR)로 41억 6,000만 달러에 달할 것으로 예상됩니다. 예측 기간의 성장은 의약품 승인 및 출시 증가, 신흥 시장, 질병 인식 및 진단 개선, 인식 제고 활동 증가, 면역 억제 제품 등에 기인합니다. 예측 기간 동안 주요 동향으로는 키메라 항원 수용체 T 세포(CAR-T) 치료, 루푸스 저분자 치료제, 루푸스 CAR-NK 치료, 전신성 홍반성 루푸스(SLE)에서 인간 형질세포 유사 수지상 세포 활성의 복합 억제, 소변 단백질체학 등이 있습니다.
루푸스 치료제 시장의 성장은 연구개발 활동의 활성화로 인해 촉진될 것으로 예상됩니다. 이러한 활동에는 다양한 분야의 지식, 기술, 제품 개발을 향상시키기 위한 체계적인 연구와 실험이 포함됩니다. R&D 활동은 혁신, 기술 발전, 새로운 과제에 대한 대응, 의료 성과 개선, 과학 기술 혁신을 통한 경제 성장 촉진 등의 필요성에 의해 추진되고 있습니다. 연구 개발 노력은 새로운 치료법을 발견하고, 기존 치료법을 강화하며, 질병의 근본적인 메커니즘을 더 잘 이해함으로써 루푸스 치료제의 발전에 기여할 수 있습니다. 예를 들어, 미국 의회조사국이 2023년 3월에 발표한 보고서에 따르면, 국립보건연구원이 2023년에 받은 연구개발비는 491억 8,300만 달러로 2021년 429억 4,100만 달러에 비해 증가하였습니다. 이 자금 지원은 루푸스 치료제와 관련된 노력을 포함한 의학 연구 추진에 대한 약속이 증가하고 있음을 강조하고 시장 성장을 촉진할 수 있습니다.
루푸스 치료제 시장에서 주요 기업들은 진단 정확도와 치료 효과를 향상시키기 위해 예측 인공지능을 접목한 첨단 혈액 검사 개발에 집중하고 있습니다. 이러한 혈액 검사는 AI 알고리즘을 활용하여 혈액 샘플의 바이오마커를 분석하여 질병의 결과와 치료 효과를 보다 정확하게 예측합니다. 예를 들어, 미국의 정밀의학 기업 AMPEL BioSolutions LLC는 2024년 3월 LuGENE 혈액 검사를 출시했습니다. 이 혁신적인 검사는 예측 AI를 통한 유전자 발현 분석을 통해 루푸스 재발을 예측하고 약물 타깃을 식별합니다. 이 검사는 염증 및 면역 기능 장애와 관련된 유전자 발현의 실시간 이상에 기반한 맞춤형 치료 옵션을 제공함으로써 루푸스 관리에 혁명을 일으키고자 합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 신종 코로나바이러스 감염증, 그리고 경기회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계 루푸스 치료제 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 이용 산업 분석
- 세계의 루푸스 치료제 시장 : 성장률 분석
- 세계의 루푸스 치료제 시장 실적 : 규모와 성장, 2019-2024
- 세계의 루푸스 치료제 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계 루푸스 치료제 전체 시장(TAM)
제6장 시장 세분화
- 세계의 루푸스 치료제 시장 : 질환 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 전신홍반루푸스(SLE)
- 피부홍반루푸스
- 약물 유발성 루푸스 홍반루푸스
- 신생아 루푸스
- 세계의 루푸스 치료제 시장 : 치료 종류별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 비스테로이드성 항염증제(NSAID)
- 생물학적 제제
- 항말라리아제
- 코르티코스테로이드
- 기타 치료 종류
- 세계의 루푸스 치료제 시장 : 투여 경로별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 경구
- 피하
- 정맥내
- 기타 투여 경로
- 세계의 루푸스 치료제 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 병원과 진료소
- 진단 검사실
- 기타 최종사용자
- 세계의 루푸스 치료제 시장, 전신홍반루푸스(SLE) 병형별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 경도 SLE
- 중등도 SLE
- 중증 SLE
- 세계의 루푸스 치료제 시장, 피부홍반루푸스 병형별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 급성 피부 루푸스
- 아 급성 피부 루푸스
- 만성 피부 루푸스(원판상 루푸스를 포함)
- 세계의 루푸스 치료제 시장, 약물 유발성 루푸스 홍반루푸스 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 약물 유발성 루푸스를 유발하는 것으로 알려진 약물
- 히드라라진
- 프로카인아마이드
- 이소니아지드
- 세계의 루푸스 치료제 시장 신생아 루푸스 하위 세분화(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 심장 관련 신생아 루푸스
- 피부 관련 신생아 루푸스
제7장 지역별·국가별 분석
- 세계의 루푸스 치료제 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 세계의 루푸스 치료제 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- 루푸스 치료제 시장 : 경쟁 구도
- 루푸스 치료제 시장 : 기업 개요
- Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
- AstraZeneca PLC
- Novartis AG
- Roche Holdings Inc.
- GlaxoSmithKline plc
- Eli Lilly and Company
- Viatris Inc.
- Teva Pharmaceutical Industries Ltd.
- Bausch Health Companies Inc.
- Sun Pharmaceutical Industries Ltd.
- Aurobindo Pharma
- Dr. Reddy's Laboratories Ltd.
- Hikma Pharmaceuticals PLC
- Amneal Pharmaceuticals LLC
- Lupin Ltd
- Zydus Lifesciences Limited
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
- 루푸스 치료제 시장 2029 : 새로운 기회를 제공하는 국가
- 루푸스 치료제 시장 2029 : 새로운 기회를 제공하는 부문
- 루푸스 치료제 시장 2029 : 성장 전략
제36장 부록
ksm
Lupus therapeutics encompass treatments and medications specifically designed to manage and alleviate the symptoms of lupus, an autoimmune disease in which the body's immune system attacks its own tissues, causing inflammation and damage in various organs. These treatments aim to reduce inflammation, suppress the overactive immune response, and improve patients' quality of life.
The primary types of lupus therapeutics include systemic lupus erythematosus, cutaneous lupus erythematosus, drug-induced lupus erythematosus, neonatal lupus, and others. Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that affects various organs and tissues, characterized by inflammation and damage to these organs. Treatments for lupus include non-steroidal anti-inflammatory drugs (NSAIDs), biologics, antimalarial drugs, corticosteroids, and others. These drugs can be administered orally, subcutaneously, intravenously, and by other methods, and are used in various settings, such as hospitals and clinics, diagnostic laboratories, and others.
The lupus therapeutics research report is one of a series of new reports from The Business Research Company that provides lupus therapeutics market statistics, including the lupus therapeutics industry's global market size, regional shares, competitors with a lupus therapeutics market share, detailed lupus therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the lupus therapeutics industry. This lupus therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The lupus therapeutics market size has grown strongly in recent years. It will grow from $2.74 billion in 2024 to $2.99 billion in 2025 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to the increased prevalence of lupus, increased investment in healthcare infrastructure, high disposable income, high demand for effective therapies, and rising geriatric population.
The lupus therapeutics market size is expected to see strong growth in the next few years. It will grow to $4.16 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to rising drug approvals and launches, emerging markets, improvements in disease awareness and diagnosis, rising awareness initiatives, and immunosuppressive products. Major trends in the forecast period include chimeric antigen receptor T-cell (CAR-T) therapy, small molecule therapeutics for lupus, CAR-NK therapy for lupus, combined inhibition of human plasmacytoid dendritic cell activity during systemic lupus, erythematosus (SLE), urine proteomics.
The growth of the lupus therapeutics market is expected to be propelled by increasing research and development activities. These activities encompass systematic investigation and experimentation aimed at advancing knowledge, technology, or product development across various fields. They are driven by the need for innovation, technological advancements, addressing emerging challenges, improving healthcare outcomes, and fostering economic growth through scientific and technological breakthroughs. Research and development efforts contribute to advancing lupus therapeutics by discovering new treatments, enhancing existing therapies, and deepening understanding of the disease's underlying mechanisms. For instance, a March 2023 report from the Congressional Research Service highlighted that the national institutes of health received $49.183 billion in 2023 for research and development activities, marking an increase from $42.941 billion allocated in 2021. This funding underscores the growing commitment to advancing medical research, including efforts related to lupus therapeutics, thereby driving market growth.
In the lupus therapeutics market, major companies are focused on developing advanced blood tests incorporating predictive artificial intelligence to improve diagnostic accuracy and treatment efficacy. These blood tests utilize AI algorithms to analyze biomarkers in blood samples, predicting disease outcomes or treatment responses more accurately. For example, AMPEL BioSolutions LLC, a US-based precision medicine company, launched the LuGENE blood test in March 2024. This innovative test predicts lupus flares and identifies drug targets through gene expression analysis with predictive AI. It aims to revolutionize lupus management by offering personalized treatment options based on real-time abnormalities in gene expression linked to inflammation and immune dysfunction.
In April 2024, Takeda Pharmaceutical Company Limited, a Japan-based biotechnology firm, acquired Nimbus Therapeutics' TYK2 program from Nimbus Lakshmi Inc. This strategic acquisition enhances Takeda's position in the immunology market and expands its portfolio of treatments for immune-mediated diseases, including lupus. Nimbus Lakshmi Inc., based in the US, specializes in developing drugs for various conditions, including lupus and psoriasis.
Major companies operating in the lupus therapeutics market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Sanofi SA, AstraZeneca PLC, Novartis AG, Roche Holdings Inc., GlaxoSmithKline plc, Eli Lilly and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Lupin Ltd, Zydus Lifesciences Limited, Glenmark Pharmaceuticals Limited
North America was the largest region in the lupus therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lupus therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the lupus therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The lupus therapeutics market consists of revenues earned by entities by providing services such as autoantibody testing, anti-phospholipid antibody testing, and rheumatoid factor testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The lupus therapeutics market also includes sales of calcineurin inhibitors, immunosuppressants, anticoagulants, and antimalarial drugs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Lupus Therapeutics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on lupus therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for lupus therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The lupus therapeutics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Disease Type: Systemic Lupus Erythematosus (SLE); Cutaneous Lupus Erythematosus; Drug-Induced Lupus Erythematosus; Neonatal Lupus
- 2) By Treatment Type: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs); Biologics; Antimalarial Drugs; Corticosteroids; Other Treatment Types
- 3) By Route Of Administration: Oral; Subcutaneous; Intravenous; Other Routes Of Administration
- 4) By End User: Hospitals And Clinics; Diagnostic Laboratories; Other End Users
- Subsegments:
- 1) By Systemic Lupus Erythematosus (SLE): Mild SLE; Moderate SLE; Severe SLE
- 2) By Cutaneous Lupus Erythematosus: Acute Cutaneous Lupus; Subacute Cutaneous Lupus; Chronic Cutaneous Lupus (Including Discoid Lupus)
- 3) By Drug-Induced Lupus Erythematosus: Medications Known To Cause Drug-Induced Lupus; Hydralazine; Procainamide; Isoniazid
- 4) By Neonatal Lupus: Heart-Related Neonatal Lupus; Skin-Related Neonatal Lupus
- Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Merck & Co. Inc.; AbbVie Inc.; Sanofi SA
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Lupus Therapeutics Market Characteristics
3. Lupus Therapeutics Market Trends And Strategies
4. Lupus Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Lupus Therapeutics Growth Analysis And Strategic Analysis Framework
- 5.1. Global Lupus Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Lupus Therapeutics Market Growth Rate Analysis
- 5.4. Global Lupus Therapeutics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Lupus Therapeutics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Lupus Therapeutics Total Addressable Market (TAM)
6. Lupus Therapeutics Market Segmentation
- 6.1. Global Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Systemic Lupus Erythematosus (SLE)
- Cutaneous Lupus Erythematosus
- Drug-Induced Lupus Erythematosus
- Neonatal Lupus
- 6.2. Global Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
- Biologics
- Antimalarial Drugs
- Corticosteroids
- Other Treatment Types
- 6.3. Global Lupus Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oral
- Subcutaneous
- Intravenous
- Other Routes Of Administration
- 6.4. Global Lupus Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals And Clinics
- Diagnostic Laboratories
- Other End Users
- 6.5. Global Lupus Therapeutics Market, Sub-Segmentation Of Systemic Lupus Erythematosus (SLE), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Mild SLE
- Moderate SLE
- Severe SLE
- 6.6. Global Lupus Therapeutics Market, Sub-Segmentation Of Cutaneous Lupus Erythematosus, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Acute Cutaneous Lupus
- Subacute Cutaneous Lupus
- Chronic Cutaneous Lupus (Including Discoid Lupus)
- 6.7. Global Lupus Therapeutics Market, Sub-Segmentation Of Drug-Induced Lupus Erythematosus, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Medications Known To Cause Drug-Induced Lupus
- Hydralazine
- Procainamide
- Isoniazid
- 6.8. Global Lupus Therapeutics Market, Sub-Segmentation Of Neonatal Lupus, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Heart-Related Neonatal Lupus
- Skin-Related Neonatal Lupus
7. Lupus Therapeutics Market Regional And Country Analysis
- 7.1. Global Lupus Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Lupus Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Lupus Therapeutics Market
- 8.1. Asia-Pacific Lupus Therapeutics Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Lupus Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Lupus Therapeutics Market
- 9.1. China Lupus Therapeutics Market Overview
- 9.2. China Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Lupus Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Lupus Therapeutics Market
- 10.1. India Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Lupus Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Lupus Therapeutics Market
- 11.1. Japan Lupus Therapeutics Market Overview
- 11.2. Japan Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Lupus Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Lupus Therapeutics Market
- 12.1. Australia Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Lupus Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Lupus Therapeutics Market
- 13.1. Indonesia Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Lupus Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Lupus Therapeutics Market
- 14.1. South Korea Lupus Therapeutics Market Overview
- 14.2. South Korea Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Lupus Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Lupus Therapeutics Market
- 15.1. Western Europe Lupus Therapeutics Market Overview
- 15.2. Western Europe Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Lupus Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Lupus Therapeutics Market
- 16.1. UK Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Lupus Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Lupus Therapeutics Market
- 17.1. Germany Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Lupus Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Lupus Therapeutics Market
- 18.1. France Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Lupus Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Lupus Therapeutics Market
- 19.1. Italy Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Lupus Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Lupus Therapeutics Market
- 20.1. Spain Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Lupus Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Lupus Therapeutics Market
- 21.1. Eastern Europe Lupus Therapeutics Market Overview
- 21.2. Eastern Europe Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Lupus Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Lupus Therapeutics Market
- 22.1. Russia Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Lupus Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Lupus Therapeutics Market
- 23.1. North America Lupus Therapeutics Market Overview
- 23.2. North America Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Lupus Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Lupus Therapeutics Market
- 24.1. USA Lupus Therapeutics Market Overview
- 24.2. USA Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Lupus Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Lupus Therapeutics Market
- 25.1. Canada Lupus Therapeutics Market Overview
- 25.2. Canada Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Lupus Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Lupus Therapeutics Market
- 26.1. South America Lupus Therapeutics Market Overview
- 26.2. South America Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Lupus Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Lupus Therapeutics Market
- 27.1. Brazil Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Lupus Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Lupus Therapeutics Market
- 28.1. Middle East Lupus Therapeutics Market Overview
- 28.2. Middle East Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Lupus Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Lupus Therapeutics Market
- 29.1. Africa Lupus Therapeutics Market Overview
- 29.2. Africa Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Lupus Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Lupus Therapeutics Market Competitive Landscape And Company Profiles
- 30.1. Lupus Therapeutics Market Competitive Landscape
- 30.2. Lupus Therapeutics Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
31. Lupus Therapeutics Market Other Major And Innovative Companies
- 31.1. AstraZeneca PLC
- 31.2. Novartis AG
- 31.3. Roche Holdings Inc.
- 31.4. GlaxoSmithKline plc
- 31.5. Eli Lilly and Company
- 31.6. Viatris Inc.
- 31.7. Teva Pharmaceutical Industries Ltd.
- 31.8. Bausch Health Companies Inc.
- 31.9. Sun Pharmaceutical Industries Ltd.
- 31.10. Aurobindo Pharma
- 31.11. Dr. Reddy's Laboratories Ltd.
- 31.12. Hikma Pharmaceuticals PLC
- 31.13. Amneal Pharmaceuticals LLC
- 31.14. Lupin Ltd
- 31.15. Zydus Lifesciences Limited
32. Global Lupus Therapeutics Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Lupus Therapeutics Market
34. Recent Developments In The Lupus Therapeutics Market
35. Lupus Therapeutics Market High Potential Countries, Segments and Strategies
- 35.1 Lupus Therapeutics Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Lupus Therapeutics Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Lupus Therapeutics Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
